RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Applied BioCode - Stock

Applied BioCode Net Income 2024

Applied BioCode Net Income

-148.48 M TWD

Ticker

6598.TW

ISIN

KYG0488D1051

In 2024, Applied BioCode's profit amounted to -148.48 M TWD, a -9.58% increase from the -164.2 M TWD profit recorded in the previous year.

The Applied BioCode Net Income history

YEARNET INCOME (undefined TWD)
2024e-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-
2015-

Applied BioCode Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Applied BioCode, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Applied BioCode from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Applied BioCode’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Applied BioCode. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Applied BioCode’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Applied BioCode’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Applied BioCode’s growth potential.

Applied BioCode Revenue, Profit, and EBIT History

DateApplied BioCode RevenueApplied BioCode EBITApplied BioCode Net Income
2024e438.6 M undefined-172.38 M undefined-148.48 M undefined
2023395.17 M undefined-186.7 M undefined-164.2 M undefined
2022390.3 M undefined-192.6 M undefined-184.73 M undefined
2021319.96 M undefined-164.94 M undefined-165.2 M undefined
2020299.02 M undefined-133.51 M undefined-103.5 M undefined
2019104.69 M undefined-275.07 M undefined-280.07 M undefined
201836.9 M undefined-267.88 M undefined-268.31 M undefined
201726.76 M undefined-263.85 M undefined-263.46 M undefined
201611.76 M undefined-194.57 M undefined-183.23 M undefined
201523.25 M undefined-221.37 M undefined-21.26 M undefined

Applied BioCode stock margins

The Applied BioCode margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Applied BioCode. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Applied BioCode.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Applied BioCode's sales revenue. A higher gross margin percentage indicates that the Applied BioCode retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Applied BioCode's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Applied BioCode's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Applied BioCode's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Applied BioCode. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Applied BioCode's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Applied BioCode Margin History

Applied BioCode Gross marginApplied BioCode Profit marginApplied BioCode EBIT marginApplied BioCode Profit margin
2024e68.01 %-39.3 %-33.85 %
202368.01 %-47.25 %-41.55 %
202260 %-49.35 %-47.33 %
202159.18 %-51.55 %-51.63 %
202064.72 %-44.65 %-34.61 %
201950.59 %-262.74 %-267.52 %
201845.34 %-725.88 %-727.04 %
201733.32 %-986.13 %-984.68 %
201641.62 %-1,654.46 %-1,558.1 %
201526.84 %-952.17 %-91.45 %

Applied BioCode Aktienanalyse

What does Applied BioCode do?

Applied BioCode Corp is a California-based company that focuses on the development and marketing of diagnostic instruments and tests. The company was founded in 2004 by an experienced management team and has since developed a number of groundbreaking technologies to improve the diagnosis of diseases such as cancer, infectious diseases, and autoimmune diseases. The business model of Applied BioCode Corp is based on the development of innovative diagnostic instruments and test systems based on proprietary technologies. The company has a strong partnership with a leading manufacturer of diagnostic automation systems, allowing a wide range of tests for various diseases to be offered. Applied BioCode Corp also works closely with leading research and development organizations to leverage the latest insights in the field of diagnostics. One of the divisions of Applied BioCode is molecular diagnostics, which is an essential component of modern medicine. Molecular diagnostics enables the detection of genetic changes and deviations related to diseases. Applied BioCode's technology allows for rapid and precise identification of pathogens in clinical samples such as blood, urine, and tissue samples. Another important area for Applied BioCode is infectious disease diagnostics. The company has developed a range of test systems based on a variety of infectious diseases such as influenza, tuberculosis, and sexually transmitted diseases such as chlamydia and gonorrhea. These tests can be performed individually or as a group to facilitate disease diagnosis and improve treatment. Applied BioCode also offers tests for the detection of oncological markers. These tests are crucial for the early detection of cancer and monitoring the treatment of cancer patients. Applied BioCode's technology enables rapid and precise identification of cancer cells in blood or tissue, which can improve the effectiveness of treatment. Another important product of Applied BioCode is the BioCode Analyzer, an automated diagnostic instrument. The BioCode Analyzer is a high-throughput system capable of performing multiple tests simultaneously. The analyzer is equipped with a disposable chip that allows for quick and easy diagnosis. This makes the BioCode Analyzer a powerful tool for laboratory automation, providing fast and accurate diagnosis for a variety of diseases. Applied BioCode is also dedicated to researching and developing new technologies. The company has an active pipeline of new products and technologies to further improve diagnostic accuracy and the number of feasible tests. Applied BioCode is also developing new applications for its technologies to improve the diagnosis and treatment of diseases in various ways. In summary, Applied BioCode Corp plays an important role in the field of diagnostic technology. The company has developed a wide range of innovative diagnostic tests and instruments that enable diseases to be quickly and accurately detected. With its strong partnership with leading diagnostic automation system manufacturers and research organizations, Applied BioCode will continue to stay at the forefront and improve diagnostic practice. Applied BioCode ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Applied BioCode's Profit Margins

The profit margins of Applied BioCode represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Applied BioCode's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Applied BioCode's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Applied BioCode's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Applied BioCode’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Applied BioCode Stock

How much profit has Applied BioCode made this year?

Applied BioCode has made -148.48 M TWD this year.

How has the profit developed compared to last year?

The profit has increased by -9.58% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Applied BioCode publish its earnings?

Applied BioCode publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Applied BioCode?

The profits of Applied BioCode are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Applied BioCode?

You can learn more about the earnings of Applied BioCode by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Applied BioCode pay?

Over the past 12 months, Applied BioCode paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Applied BioCode is expected to pay a dividend of 0 TWD.

What is the dividend yield of Applied BioCode?

The current dividend yield of Applied BioCode is .

When does Applied BioCode pay dividends?

Applied BioCode pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Applied BioCode?

Applied BioCode paid dividends every year for the past 0 years.

What is the dividend of Applied BioCode?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Applied BioCode located?

Applied BioCode is assigned to the 'Health' sector.

Wann musste ich die Aktien von Applied BioCode kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Applied BioCode from 6/17/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 6/17/2024.

When did Applied BioCode pay the last dividend?

The last dividend was paid out on 6/17/2024.

What was the dividend of Applied BioCode in the year 2023?

In the year 2023, Applied BioCode distributed 0 TWD as dividends.

In which currency does Applied BioCode pay out the dividend?

The dividends of Applied BioCode are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Applied BioCode

Our stock analysis for Applied BioCode Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Applied BioCode Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.